Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovarest Dose-Finding Study in Endometriosis
NCT05096065Phase 2Unknown
- Sponsor
- Enteris BioPharma
- Start
- Mar 2022
- Primary completion
- May 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ovarest in endometriosis, sponsored by Enteris BioPharma. Status: unknown.
02
Drugs
Ovarest
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT05096065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096065.